Published guidance, NICE advice and quality standards | Guidance

Showing 291 to 300 of 1904

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Axicabtagene ciloleucel for treating diffuse large B-cell lymphoma and primary mediastinal large B-cell lymphoma after 2 or more systemic therapies	TA872	28 February 2023	28 February 2023
Ixazomib with lenalidomide and dexamethasone for treating relapsed or refractory multiple myeloma	TA870	22 February 2023	22 February 2023
Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene	HST22	22 February 2023	22 February 2023
Mitapivat for treating pyruvate kinase deficiency (terminated appraisal)	TA867	16 February 2023	16 February 2023
Vutrisiran for treating hereditary transthyretin-related amyloidosis	TA868	15 February 2023	15 February 2023
Nivolumab with fluoropyrimidine- and platinum-based chemotherapy for untreated unresectable advanced, recurrent, or metastatic oesophageal squamous cell carcinoma	TA865	8 February 2023	8 February 2023
Regorafenib for previously treated metastatic colorectal cancer	TA866	8 February 2023	8 February 2023
Barrett's oesophagus and stage 1 oesophageal adenocarcinoma: monitoring and management	NG231	8 February 2023	8 February 2023
Transvenous obliteration for gastric varices	IPG751	7 February 2023	7 February 2023
Biodegradable spacer insertion to reduce rectal toxicity during radiotherapy for prostate cancer	IPG752	7 February 2023	7 February 2023